GlassScriptPhysician profile
Scott G Thomas
NPI 1033196126
$2,855.32
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $522 · 2020: $203 · 2021: $45.10 · 2023: $2,040 · 2024: $45.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,302 · Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,302.44 |
| Food and Beverage | $782.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,583.04 | 2023 | Advantagerib, Ribfix Blu Advantage |
| Haemonetics Corporation | $218.82 | 2019-2024 | Teg6s Hemostasis System |
| Intuitive Surgical, INC. | $193.54 | 2019-2023 | Da Vinci Surgical System |
| Stryker Corporation | $168.46 | 2020 | |
| Avanos Medical | $142.31 | 2019 | |
| Tela Bio, INC. | $136.60 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $99.68 | 2019 | |
| Prytime Medical Devices, INC. | $95.71 | 2023 | Er-Reboa Plus |
| Cerus Corporation | $48.16 | 2023-2024 | Intercept Blood System For Platelets |
| Astrazeneca Pharmaceuticals LP | $27.98 | 2023 | Andexxa |
| Portola Pharmaceuticals, LLC | $27.64 | 2019 | |
| Davol INC. | $22.09 | 2020 | |
| Baxter Healthcare | $20.29 | 2021 | |
| Bard Peripheral Vascular, INC. | $18.63 | 2019 | |
| W. L. Gore & Associates, INC. | $14.17 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13.16 | 2021 | |
| Merck Sharp & Dohme LLC | $12.84 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.